Coronavirus pill



First generic version of new Pfizer COVID-19 pill enters Bangladeshi pharmacies

  • In trials, Paxlovid reduced the risk of COVID-19-related hospitalization and death by 89 percent
  • Pfizer’s treatment is protected by patents, but least-developed countries such as Bangladesh are not bound by them
By SHEHAB SUMON ·